Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies
- PMID: 15307110
- DOI: 10.1002/ajh.20147
Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies
Abstract
Reversible posterior leukoencephalopathy syndrome (RPLS) is an uncommon but distinctive clinicoradiological entity comprising of headache, seizures, visual disturbance, and altered mental function, in association with posterior cerebral white matter edema. With appropriate management, RPLS is reversible in the majority of cases. Previous reported associations of RPLS include hypertension, eclampsia, renal failure, and use of immunosuppressive drugs; reports in the adult hematology setting are rare. We report two cases of adults undergoing treatment for hematological malignancies who developed RPLS, and we emphasize the importance of early recognition and institution of appropriate management in reducing the risk of development of permanent neurological disability.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
-
[Reversible posterior encephalopathy syndrome: case report].Arq Neuropsiquiatr. 2002 Sep;60(3-A):651-55. Arq Neuropsiquiatr. 2002. PMID: 12244391 Portuguese.
-
[Clinical features of preeclampsia-eclampsia patients with reversible posterior leukoencephalopathy syndrome].Zhonghua Yi Xue Za Zhi. 2010 Jan 19;90(3):178-81. Zhonghua Yi Xue Za Zhi. 2010. PMID: 20356553 Clinical Trial. Chinese.
-
Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy.Neuroradiology. 2006 Dec;48(12):887-92. doi: 10.1007/s00234-006-0142-8. Epub 2006 Sep 16. Neuroradiology. 2006. PMID: 16983525
-
Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature.Lupus. 2008 Feb;17(2):139-47. doi: 10.1177/0961203307085405. Lupus. 2008. PMID: 18250139 Review.
-
Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus.Semin Arthritis Rheum. 2006 Jun;35(6):396-402. doi: 10.1016/j.semarthrit.2006.01.002. Semin Arthritis Rheum. 2006. PMID: 16765717 Review.
Cited by
-
Reversible posterior leukoencephalopathy induced by carboplatin and etoposide.Med Oncol. 2012 Jun;29(2):1287-91. doi: 10.1007/s12032-011-9898-8. Epub 2011 Mar 10. Med Oncol. 2012. PMID: 21390516
-
Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.Neurologist. 2016 Nov;21(6):112-117. doi: 10.1097/NRL.0000000000000105. Neurologist. 2016. PMID: 27801773 Free PMC article.
-
Reversible posterior leukoencephalopathy syndrome following apatinib for gastric cancer in an adult: A case report and a review of the literature.Medicine (Baltimore). 2019 Nov;98(46):e17787. doi: 10.1097/MD.0000000000017787. Medicine (Baltimore). 2019. PMID: 31725620 Free PMC article.
-
Posterior Reversible Encephalopathy Syndrome in Pediatric Cancer: Clinical and Radiologic Findings.J Glob Oncol. 2018 Sep;4:1-8. doi: 10.1200/JGO.17.00089. Epub 2017 Dec 4. J Glob Oncol. 2018. PMID: 30241146 Free PMC article.
-
Fatal outcome of posterior "reversible" encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen.World J Surg Oncol. 2014 Aug 20;12:264. doi: 10.1186/1477-7819-12-264. World J Surg Oncol. 2014. PMID: 25142792 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources